Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acti Colla C
- Development stage
- Unknown
- Lead developer
- Eva Pharma
- Modality
- Peptides, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Acti Colla C is an oral dietary supplement formulated by Eva Pharma to support joint and bone health. It is a triple-action combination containing hydrolyzed collagen (marine collagen), rosehip extract, and vitamin C (ascorbic acid). Hydrolyzed collagen provides essential amino acids like glycine and proline to support cartilage regeneration and joint integrity. Rosehip extract offers natural anti-inflammatory benefits to reduce joint stiffness and pain, while vitamin C acts as an antioxidant and a crucial cofactor for endogenous collagen synthesis. It is typically administered orally as a powder dissolved in water for the management of joint discomfort, osteoarthritis, and to support overall mobility.
- Brand names
- Acti Colla CActi-Colla C
- Other names
- collagen hydrolysate + rosehips + ascorbic acidhydrolyzed collagen + rosehip + ascorbic acid
02
Targets
PHD1 (Prolyl hydroxylase domain-containing protein 1)
Beyond the preview
Go deeper on Acti Colla C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acti Colla C.